Annie Curtis

Annie Curtis is an Irish immunologist at the Royal College of Surgeons in Ireland whose career has spanned academia, public sector and industry. She studies how the power of the body clock can be harnessed to control inflammatory diseases. 
Education.
Curtis completed a B.A in Genetics in Trinity College Dublin (1994-1998) and conducted her PhD in the laboratory of Prof. Garret FitzGerald in Pharmacology (2001 – 2006) at University of Pennsylvania. Here she became aware of body clocks and found out how the clock controls cardiovascular function.
Career.
Curtis was recruited to GlaxoSmithKline in Philadelphia as a Principal Scientist directly after completing her PhD, where she led a small research team researching biomarkers for cardiovascular risk between 2006–2008. In 2008 she was recruited as Scientific Programme Manager for Science Foundation Ireland (SFI) until 2010 when she was employed as Medical Advisor for Immunotherapeutics with Bristol-Myers Squibb.
In 2011, she joined the laboratory of Luke O’Neill in biochemistry at Trinity College Dublin. In 2014, she was awarded an SFI Starting Investigator Research Grant to establish a group studying the impact of clocks on the immune system. Curtis joined the Royal College of Surgeons in Ireland as a research lecturer in Molecular and Cellular Therapeutics in August 2016. Her work has led to the understanding of mechanisms inducing chronic inflammatory diseases like multiple sclerosis which is linked to the disruption of the body clock.
Awards.
2017: L'Oréal-UNESCO For Women in Science UK & Ireland Fellowships 2017 Fellowship, L'Oréal-UNESCO
2012: Winner, Roche Medal, Researcher of the Year, Trinity Biomedical Science Institute, Roche Pharmaceuticals
2006: Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Junior Investigator Award for Women 2006, ATVB